← Back to Clinical Trials
Recruiting NCT06620601

NCT06620601 Digital Technology for Sleep and Homelessness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06620601
Status Recruiting
Phase
Sponsor University Health Network, Toronto
Condition Sleep Apnea
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2021-10-20
Primary Completion 2024-10

Trial Parameters

Condition Sleep Apnea
Sponsor University Health Network, Toronto
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-10-20
Completion 2024-10
Interventions
Portable PolysomnographyTreatmentQuestionnaires

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In Canada, 35,000 people are experiencing homelessness on any night. Compared to the general population, people experiencing homelessness (PEH) sleep less and experience increased daytime fatigue. A common sleep disorder and treatable cause of morbidity and low quality of life is sleep apnea. High prevalence of chronic comorbid disorders of sleep apnea in PEH suggest high prevalence of sleep apnea, but the rate of sleep apnea treatment in PEH is very low. Also, in PEH, individual and systemic barriers lead to a high rate of underdiagnosed and untreated sleep apnea. Mortality is higher in PEH than the general population, and sleep apnea remains a potential silent cause of morbidity and low quality of life in PEH. Our goal is to diagnose and treat sleep apnea in people living in shelters and to examine the effect of patient-centered treatment on their quality of life.

Eligibility Criteria

Inclusion Criteria: * Residing in a shelter at the time of recruitment * Age \>18 years old Exclusion Criteria: * Allergies to medical tape \[for diagnosis study\]. * Requiring extensive dental treatment or periodontal disease with tooth mobility \[for treatment study\].

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology